These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9073302)
1. The protective effect of MK-801 on infarct development over a period of 24 h as assessed by diffusion-weighted magnetic resonance imaging. Gill R; Sibson NR; Maskell L; Carpenter TA; Hall LD; Pickard JD NMR Biomed; 1996 Sep; 9(6):241-8. PubMed ID: 9073302 [TBL] [Abstract][Full Text] [Related]
2. A comparison of the early development of ischaemic damage following permanent middle cerebral artery occlusion in rats as assessed using magnetic resonance imaging and histology. Gill R; Sibson NR; Hatfield RH; Burdett NG; Carpenter TA; Hall LD; Pickard JD J Cereb Blood Flow Metab; 1995 Jan; 15(1):1-11. PubMed ID: 7798326 [TBL] [Abstract][Full Text] [Related]
3. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720 [TBL] [Abstract][Full Text] [Related]
4. [Application of diffusion-weighted and perfusion magnetic resonance imaging in definition of the ischemic penumbra in hyperacute cerebral infarction]. Feng XY; Liang J; Yin XD; Han X; Dong Q; Lü CZ Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):952-7. PubMed ID: 12899795 [TBL] [Abstract][Full Text] [Related]
5. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice. Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319 [TBL] [Abstract][Full Text] [Related]
6. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof]. Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678 [TBL] [Abstract][Full Text] [Related]
7. Short therapeutic window for MK-801 in transient focal cerebral ischemia in normotensive rats. Margaill I; Parmentier S; Callebert J; Allix M; Boulu RG; Plotkine M J Cereb Blood Flow Metab; 1996 Jan; 16(1):107-13. PubMed ID: 8530543 [TBL] [Abstract][Full Text] [Related]
8. Polynitroxyl albumin reduces infarct size in transient focal cerebral ischemia in the rat: potential mechanisms studied by magnetic resonance imaging. Beaulieu C; Busch E; Röther J; de Crespigny A; Hsia CJ; Moseley ME J Cereb Blood Flow Metab; 1998 Sep; 18(9):1022-31. PubMed ID: 9740106 [TBL] [Abstract][Full Text] [Related]
9. Potassium-induced cortical spreading depressions during focal cerebral ischemia in rats: contribution to lesion growth assessed by diffusion-weighted NMR and biochemical imaging. Busch E; Gyngell ML; Eis M; Hoehn-Berlage M; Hossmann KA J Cereb Blood Flow Metab; 1996 Nov; 16(6):1090-9. PubMed ID: 8898680 [TBL] [Abstract][Full Text] [Related]
10. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia. Dawson DA; Graham DI; McCulloch J; Macrae IM Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111 [TBL] [Abstract][Full Text] [Related]
11. The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat. Bordi F; Pietra C; Ziviani L; Reggiani A Exp Neurol; 1997 Jun; 145(2 Pt 1):425-33. PubMed ID: 9217078 [TBL] [Abstract][Full Text] [Related]
12. D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats. Esneault E; Castagne V; Moser P; Bonny C; Bernaudin M Neuroscience; 2008 Mar; 152(2):308-20. PubMed ID: 18262367 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia. Lo EH; Matsumoto K; Pierce AR; Garrido L; Luttinger D J Cereb Blood Flow Metab; 1994 Jul; 14(4):597-603. PubMed ID: 8014206 [TBL] [Abstract][Full Text] [Related]
14. [Diffusion-weighted magnetic resonance tomography: a highly promising MR technic for the early recognition of cerebral ischemia]. Reith W; Heiland S; Forsting M; Fisher M; Sartor K Rofo; 1997 Feb; 166(2):133-9. PubMed ID: 9116255 [TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted magnetic resonance imaging during brief focal cerebral ischemia and early reperfusion: evolution of delayed infarction in rats. Zarow GJ; Graham SH; Mintorovitch J; Chen J; Yang G; Weinstein PR Neurol Res; 1995 Dec; 17(6):449-54. PubMed ID: 8622801 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective properties of the non-peptidyl radical scavenger IAC in rats following transient focal cerebral ischemia. Nurmi A; Miettinen TK; Puoliväli J; Pussinen R; Soleti A; Bagate K; Riccardino F; Grundy RI; Yrjänheikki J; Canistro D; Paolini M Brain Res; 2008 May; 1207():174-81. PubMed ID: 18374313 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of hyperbaric oxygen therapy monitored by MR-imaging after embolic stroke in rats. Henninger N; Küppers-Tiedt L; Sicard KM; Günther A; Schneider D; Schwab S Exp Neurol; 2006 Oct; 201(2):316-23. PubMed ID: 16814772 [TBL] [Abstract][Full Text] [Related]
18. Volumetric evaluation of the ischemic lesion size with serial MRI in a transient MCAO model of the rat: comparison of DWI and T1WI. Nagel S; Wagner S; Koziol J; Kluge B; Heiland S Brain Res Brain Res Protoc; 2004 Feb; 12(3):172-9. PubMed ID: 15013468 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies. Williams AJ; Dave JR; Phillips JB; Lin Y; McCabe RT; Tortella FC J Pharmacol Exp Ther; 2000 Jul; 294(1):378-86. PubMed ID: 10871336 [TBL] [Abstract][Full Text] [Related]
20. Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats. Allahtavakoli M; Shabanzadeh A; Roohbakhsh A; Pourshanazari A Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):309-14. PubMed ID: 17910613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]